Bayer to seek approval for new hemophilia drug by year-end

FRANKFURT (Reuters) - German drugmaker Bayer AG will file for regulatory approval of its experimental hemophilia drug Bay 81-8973 by the end of the year, it said on Tuesday.

via Reuters: Health News Read More Here..